Mallinckrodt settles US opioid lawsuit
Firm will pay $35m over allegations it failed to report suspicious orders of controlled substances
Generic drugmaker Mallinckrodt has agreed to pay $35 million to settle a lawsuit brought by the US department of justice over opioid painkillers. The company has not admitted any fault, but is accused of failing to properly detect and notify the US Drug Enforcement Agency of suspicious orders of controlled substances such as oxycodone. The settlement also covers problems with the company’s manufacturing batch records at its plant in Hobart, US.